Medistim ASA Asset Resilience Ratio
Medistim ASA asset resilience ratio. Medistim ASA (MEDI) has an Asset Resilience Ratio of 29.72% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MEDI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medistim ASA (2016–2021)
Asset resilience ratio of Medistim ASA from 2016 to 2021. This chart shows how Medistim ASA's Asset Resilience Ratio has changed over time. Read Medistim ASA balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medistim ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Medistim ASA assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr183.45 Million | 29.72% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr183.45 Million | 29.72% |
Asset Resilience Insights
- Very High Liquidity: Medistim ASA maintains exceptional liquid asset reserves at 29.72% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Medistim ASA Industry Peers by Asset Resilience Ratio
Compare Medistim ASA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Medistim ASA Asset Resilience Ratio by Year (2016–2021)
Medistim ASA asset resilience ratio by year from 2016 to 2021. The table below shows the annual Asset Resilience Ratio data for Medistim ASA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 32.11% | Nkr129.49 Million ≈ $13.63 Million |
Nkr403.24 Million ≈ $42.43 Million |
+11.32pp |
| 2020-12-31 | 20.79% | Nkr71.89 Million ≈ $7.57 Million |
Nkr345.82 Million ≈ $36.39 Million |
+0.93pp |
| 2019-12-31 | 19.86% | Nkr66.75 Million ≈ $7.02 Million |
Nkr336.11 Million ≈ $35.37 Million |
+2.24pp |
| 2018-12-31 | 17.62% | Nkr47.49 Million ≈ $5.00 Million |
Nkr269.59 Million ≈ $28.37 Million |
-4.06pp |
| 2017-12-31 | 21.67% | Nkr54.41 Million ≈ $5.73 Million |
Nkr251.06 Million ≈ $26.42 Million |
+7.36pp |
| 2016-12-31 | 14.31% | Nkr31.07 Million ≈ $3.27 Million |
Nkr217.05 Million ≈ $22.84 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more